Colorectal Cancer Trial, Recruiting NCT06976710 Sponsor: Surgical Outcomes Research Centre (SOuRCe) Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06976710
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are scheduled to have planned (non-emergency) major surgery for colon or rectal cancer, with the goal of curing the cancer
  • People who have an appointment with a colorectal cancer surgeon at least one week before their scheduled surgery date

Who may not be able to join:

  • People who are having certain more extensive surgical procedures, specifically pelvic exenteration, cytoreductive surgery (with or without a heated chemotherapy wash called HIPEC), or surgery at the same time to treat cancer that has spread to other parts of the body
  • People who have a cognitive impairment (such as a condition affecting memory or thinking) that would prevent them from being able to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 02 9515 3203

Australian sites

Coffs Harbour Health Campus, Coffs Harbour, New South Wales
Calvary Mater Hospital, Newcastle, New South Wales
John Hunter Hospital, Newcastle, New South Wales
Chris O'Brien Lifehouse, Sydney, New South Wales
Royal Prince Alfred Hospital, Sydney, New South Wales
+61 02 9515 3203
Concord Repatriation General Hospital, Sydney, New South Wales
Westmead Hospital, Sydney, New South Wales
Blacktown Hospital, Sydney, New South Wales
Wagga Wagga Base Hospital, Wagga Wagga, New South Wales
Wollongong Hospital, Wollongong, New South Wales
Royal Brisbane & Women's Hospital, Brisbane, Queensland
Princess Alexandra Hospital, Brisbane, Queensland
The Queen Elizabeth II Jubilee Hospital, Brisbane, Queensland
Royal Adelaide Hospital, Adelaide, South Australia
Flinders Medical Centre, Adelaide, South Australia
Modbury Hospital, Adelaide, South Australia
Lyell McEwin Hospital, Adelaide, South Australia
Grampians Health Ballarat Hospital, Ballarat, Victoria
Bendigo Health, Bendigo, Victoria
University Hospital Geelong (Barwon Health), Geelong, Victoria
Peter MacCallum Cancer Centre, Melbourne, Victoria
Alfred Hospital, Melbourne, Victoria
Footscray Hospital, Melbourne, Victoria
Werribee Mercy Hospital, Melbourne, Victoria
Royal Melbourne Hospital, Melbourne, Victoria
St Vincent's Melbourne Hospital, Melbourne, Victoria
Northern Hospital Epping, Melbourne, Victoria
Austin Hospital, Melbourne, Victoria
Eastern (Box Hill) Hospital, Melbourne, Victoria
Cabrini Hospital, Melbourne, Victoria
Royal Perth Hospital, Perth, Western Australia

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Surgical Outcomes Research Centre (SOuRCe)
Registry
ClinicalTrials.gov
Start date
15 October 2025
Est. completion
30 July 2028

Where this trial is recruiting

🇦🇺 Australia

31 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Proportion of participants developing postoperative complications within 30 days after surgery.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov